 Allergens
"Allergens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
| Descriptor ID |
D000485
|
| MeSH Number(s) |
D23.050.063
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Allergens".
Below are MeSH descriptors whose meaning is more specific than "Allergens".
This graph shows the total number of publications written about "Allergens" by people in this website by year, and whether "Allergens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1999 | 1 | 1 | 2 | | 2001 | 1 | 0 | 1 | | 2002 | 1 | 3 | 4 | | 2003 | 4 | 5 | 9 | | 2004 | 3 | 2 | 5 | | 2005 | 5 | 2 | 7 | | 2006 | 3 | 6 | 9 | | 2007 | 3 | 0 | 3 | | 2008 | 5 | 6 | 11 | | 2009 | 7 | 8 | 15 | | 2010 | 7 | 5 | 12 | | 2011 | 6 | 2 | 8 | | 2012 | 5 | 4 | 9 | | 2013 | 7 | 3 | 10 | | 2014 | 6 | 0 | 6 | | 2015 | 5 | 10 | 15 | | 2016 | 6 | 9 | 15 | | 2017 | 10 | 13 | 23 | | 2018 | 15 | 10 | 25 | | 2019 | 10 | 4 | 14 | | 2020 | 10 | 22 | 32 | | 2021 | 4 | 22 | 26 | | 2022 | 2 | 21 | 23 | | 2023 | 3 | 31 | 34 | | 2024 | 8 | 19 | 27 | | 2025 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Allergens" by people in Profiles.
-
Anagnostou A, Greenhawt M. Epicutaneous immunotherapy: A review of safety and efficacy. Pediatr Allergy Immunol. 2025 Apr; 36(4):e70096.
-
Venter C, Groetch M. Emerging concepts in introducing foods for food allergy prevention. Curr Opin Clin Nutr Metab Care. 2025 May 01; 28(3):263-273.
-
Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Anvari S, Berger WE, Bird JA, Chan ES, Chinthrajah RS, Chong HJ, Fineman SM, Fleischer DM, Gonzalez-Reyes E, Kim EH, Lanser BJ, MacGinnitie A, Mehta H, Petroni D, Rupp N, Schneider LC, Scurlock AM, Sher LD, Shreffler WG, Sindher SB, Wood R, Yang WH, Sampson HA, Bois T, Green TD, Campbell DE, Bee KJ, B?gin P. Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study). J Allergy Clin Immunol Pract. 2025 May; 13(5):1190-1200.e3.
-
Greenhawt M, Albright D, Anvari S, Arends N, Arkwright PD, B?gin P, Bl?mchen K, Brown-Whitehorn T, Cassell H, Chan ES, Ciaccio CE, Deschildre A, Divaret-Chauveau A, Dorris S, Dorsey M, Du Toit G, Eiwegger T, Erlewyn-Lajeunesse M, Fleischer DM, Ford LS, Garcia-Lloret M, O'B Hourihane J, Jay N, Jones SM, Kim EH, Kloepfer K, Leonard S, Lezmi G, Lieberman J, Lomas J, Makhija M, O'Sullivan M, Parrish C, Peake J, Perrett KP, Petroni D, Pongracic JA, Quinn P, Robison RG, Sanders G, Schneider L, Sharma H, Sindher SB, Trujillo J, Turner PJ, Tuttle K, Upton J, Varshney P, Vickery BP, Vogelberg C, Wainstein B, Wang J, Wood R, Bee KJ, Campbell DE, Green TD, Rouissi R, Bahnson HT, Bois T, Sampson HA, Burks AW. Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE. J Allergy Clin Immunol Pract. 2025 May; 13(5):1176-1187.e7.
-
Brough HA, Kim EH, Anagnostou A, Lanser BJ, Chinthrajah RS, Sindher SB. Treatment of Food Allergy: Immunotherapy, Omalizumab, or Both. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):731-739.
-
Lloyd M, Morton JI, Peters RL, Loke P, Ashley S, Shaker MS, Greenhawt M, Ademi Z, Tang MLK. Cost-Effectiveness of Oral Immunotherapy for Egg Allergy According to Age of Therapy Commencement. J Allergy Clin Immunol Pract. 2025 Mar; 13(3):619-629.
-
Pickett-Nairne K, Glueck D, Thomson J, Weiss R, Fuller KNZ, Fabbri S, Schaefer C, Evans C, Bowhay E, Martinez M, Moore W, Fleischer D, Venter C. Validation of a Food Frequency Questionnaire: VioScreen-Allergy. Nutrients. 2024 Nov 02; 16(21).
-
Pollock J, Watson N, Pittman L, Schwartz D. Ultrafiltered dog allergen skin test compared with acetone precipitated and conventional dog: A retrospective study. Allergy Asthma Proc. 2024 Nov 01; 45(6):453-455.
-
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fiocchi A, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, O'B Hourihane J, Jones CJ, Jutel M, Knol EF, Konstantinou GN, Lack G, Lau S, Mejias AM, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, de Oliveira LCL, O'Mahony L, Papadopoulos NG, Perrett KP, Peters R, Podesta M, Poulsen LK, Roberts G, Sampson H, Schwarze J, Smith P, Tham E, Untersmayr E, Van Ree R, Venter C, Vickery B, Vlieg-Boerstra B, Werfel T, Worm M, Du Toit G, Skypala I. EAACI guidelines on the management of IgE-mediated food allergy. Allergy. 2025 Jan; 80(1):14-36.
-
Gauvreau GM, Sehmi R, FitzGerald JM, Leigh R, Cockcroft DW, Davis BE, Mayers I, Boulet LP, Al-Sajee D, Salter BM, Cusack RP, Ho T, Whetstone CE, Alsaji N, Satia I, Killian KJ, Mitchell PD, Magee IP, Bergeron C, Bhutani M, Werkstr?m V, Durzynski T, Shoemaker K, Katial RK, Jison M, Newbold P, McCrae C, O'Byrne PM. Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial. Eur Respir J. 2024 Sep; 64(3).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|